Opioid Overdose Crisis (III)

Published: Jan. 16, 2019, 9:35 p.m.

Carol Ott, Pharm.D., BCPP\xa0- Clinical Professor of Pharmacy Practice, Purdue University College of Pharmacy and Residency Program Director for the Eskenazi Health/Purdue\xa0University PGY2 Psychiatric Pharmacy Residency Program - discusses how sigma adversely impacts patients with opioid\xa0use disorder and how the BoilerwoRx program is helping to address the opioid crises at the community level.\nKey Lessons\nHealth professionals too often use stigmatizing language when describing patients with a substance use disorder and their behaviors.\nWe need to critically examine our unconscious biases toward patients with substance use disorder.\nSubstance use disorders are most often co-morbid with other mental health conditions.\nNeedle exchange programs are an evidence-based intervention that can reduce harm by preventing the spread of infectious diseases and be an important touchpoint to get people into treatment.\nThere are numerous ways pharmacists can help patients with substance use disorders - approaching them with empathy, volunteering, and using evidence-based resources to guide care and combat misinformation.\nView and Download the ShowNotes!